Highlander Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Highlander Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$87.8K	–	972
2023 Q4	$87.8K	Hold	100	–	–	0.03%	313
2023 Q3	$82K	Hold	100	–	–	0.03%	301
2023 Q2	$72K	Hold	100	–	–	0.03%	274
2023 Q1	$82K	Hold	100	–	–	0.04%	257
2022 Q4	$72K	Hold	100	–	–	0.04%	253
2022 Q3	$69K	Sell	100 -100	-50%	-$62.9K	0.04%	245
2022 Q2	$118K	Hold	200	–	–	0.06%	194
2022 Q1	$140K	Buy	200 +50	+33%	+$31.6K	0.07%	180
2021 Q4	$95K	Hold	150	–	–	0.04%	218
2021 Q3	$91K	Hold	150	–	–	0.05%	220
2021 Q2	$84K	Hold	150	–	–	0.04%	233
2021 Q1	$71K	Hold	150	–	–	0.04%	245
2020 Q4	$72K	Buy	150 +100	+200%	+$54K	0.04%	234
2020 Q3	$28K	Hold	50	–	–	0.02%	358
2020 Q2	$31K	Hold	50	–	–	0.02%	340
2020 Q1	$24K	Hold	50	–	–	0.02%	375
2019 Q4	$19K	Hold	50	–	–	0.01%	440
2019 Q3	$14K	Hold	50	–	–	0.01%	490
2019 Q2	$16K	Hold	50	–	–	0.01%	492
2019 Q1	$21K	Hold	50	–	–	0.01%	453
2018 Q4	$19K	Hold	50	–	–	0.01%	460
2018 Q3	$20K	Hold	50	–	–	0.01%	500
2018 Q2	$17K	Hold	50	–	–	0.01%	535
2018 Q1	$16K	Hold	50	–	–	0.01%	530
2017 Q4	$19K	Sell	50 -150	-75%	-$60.8K	0.01%	508
2017 Q3	$89K	Hold	200	–	–	0.07%	269
2017 Q2	$98K	Buy	+200	New	+$87.5K	0.08%	258

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Highlander Capital Management's REGN Position: Q1 2024 in Review

Highlander Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 100 shares — an estimated $87.8K sold.

Highlander Capital Management first reported a position in REGN in Q2 2017 and held it in 27 quarters. The position peaked at $140K in Q1 2022. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

Highlander Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Highlander Capital Management sold 100 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $87.8K.
Highlander Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2017 and held it in 27 quarters.
Highlander Capital Management's Regeneron Pharmaceuticals position peaked at $140K in Q1 2022.
1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.